33
Participants
Start Date
December 13, 2021
Primary Completion Date
January 31, 2024
Study Completion Date
January 31, 2024
Hydrus Microstent
Minimally invasive glaucoma surgery device implanted into the Schlemm's canal of the eye to provide a natural outflow pathway for aqueous humor, leading to a reduction in intraocular pressure (IOP). The Hydrus Microstent is intended for lifetime use of the glaucoma patient.
Ophthalmic surgery
Implantation of the Hydrus Microstent performed under either local or topical ophthalmic anesthesia
The Eye Clinic of Florida, Zephyrhills
Cincinnati Eye / Apex Eye, Mason
Fraser Eye Care Center, Fraser
Eye Centers Of Racine And Kenosha, Kenosha
Vold Vision PLLC, Bentonville
Lead Sponsor
Alcon Research
INDUSTRY